Choosing the Right Endpoints | Eye to Market Episode 7

LEGAL DISCLAIMER*: This content is for informational purposes only and does not constitute legal, medical, regulatory, or financial advice. How do you choose the right endpoints for an ophthalmic clinical trial? In Episode 7 of Eye to Market, experts discuss endpoint selection, clinical trial design, patient-reported outcomes, proof of concept studies, and strategies for reducing risk throughout the development process. Topics include: • Selecting meaningful clinical trial endpoints • Patient-reported outcomes and patient experience • De-risking ophthalmic development programs • Proof of concept and early-stage studies • Regulatory and stakeholder considerations • Designing studies that generate actionable evidence Eye to Market is a video series exploring the science, strategy, and innovation shaping the future of ophthalmology in collaboration with Ora Clinical and Unither Pharmaceuticals. Subscribe for more conversations with innovators, clinicians, entrepreneurs, investors, and industry leaders advancing eye care. #Ophthalmology #ClinicalTrials #DrugDevelopment #ClinicalResearch #Biotech #EyeCareInnovation *The views and opinions expressed in this series are those of the individual participants and do not necessarily reflect those of Eyecelerator, Ora, Unither, or their affiliates. This content is provided for informational and educational purposes only and is not intended, and should not be relied upon, as legal, medical, regulatory, financial, or professional advice. Nothing herein constitutes an endorsement or an offer to buy or sell any securities. Viewers should consult qualified professionals regarding their specific circumstances before making any decisions.